Your browser doesn't support javascript.
loading
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.
Welzel, T M; Hinrichsen, H; Sarrazin, C; Buggisch, P; Baumgarten, A; Christensen, S; Berg, T; Mauss, S; Teuber, G; Stein, K; Deterding, K; van Bömmel, F; Heyne, R; John, C; Zimmermann, T; Lutz, T; Schott, E; Hettinger, J; Kleine, H; König, B; Hüppe, D; Wedemeyer, H.
Affiliation
  • Welzel TM; Department of Medicine 1, University Hospital, J.W. Goethe University, Frankfurt am Main, Germany.
  • Hinrichsen H; Gastroenterology-Hepatology Center Kiel, Kiel, Germany.
  • Sarrazin C; Department of Medicine 1, University Hospital, J.W. Goethe University, Frankfurt am Main, Germany.
  • Buggisch P; Medical Department II, Gastroenterology, Hepatology, Infectiology, St. Josefs-Hospital, Wiesbaden, Germany.
  • Baumgarten A; Liver Unit, Asklepios Clinic St. Georg, IFI-Institute, Hamburg, Germany.
  • Christensen S; Center for Infectiology Berlin, Berlin, Germany.
  • Berg T; Center for Interdisciplinary Medicine (CIM), Münster, Germany.
  • Mauss S; Section of Hepatology, Clinic for Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany.
  • Teuber G; Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
  • Stein K; Private Practice, Frankfurt am Main, Germany.
  • Deterding K; Hepatologie - Magdeburg, Magdeburg, Germany.
  • van Bömmel F; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Heyne R; Section of Hepatology, Clinic for Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany.
  • John C; Leberzentrum am Checkpoint Berlin, Berlin, Germany.
  • Zimmermann T; Private Practice for Internal Medicine, Berlin, Germany.
  • Lutz T; Department of Medicine I, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Schott E; Infektiologikum, Frankfurt am Main, Germany.
  • Hettinger J; Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Kleine H; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany.
  • König B; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany.
  • Hüppe D; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany.
  • Wedemeyer H; Center for Gastroenterology and Hepatology, Herne.
J Viral Hepat ; 24(10): 840-849, 2017 10.
Article in En | MEDLINE | ID: mdl-28342229
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Uracil / Carbamates / Ritonavir / Hepatitis C, Chronic / Macrocyclic Compounds / Anilides Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2017 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Uracil / Carbamates / Ritonavir / Hepatitis C, Chronic / Macrocyclic Compounds / Anilides Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2017 Type: Article Affiliation country: Germany